Stock SGHT SIGHT SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-20 EDT 		5-day change 1st Jan Change
5.67 USD +6.18% Intraday chart for Sight Sciences, Inc. +4.61% +9.88%
05-14 Transcript : Sight Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:15 AM
05-03 Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed
MT
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q1 Revenue $19.3M, vs. Street Est of $18.4M
MT
Sight Sciences, Inc. Provides Revenue Guidance for the Second Half of 2024 and Re-Affirms Earnings Guidance for the Full Year 2024
CI
Sight Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Edge Higher Late Afternoon
MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading
MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
MT
Sight Sciences, Inc. Announces the Publication of Large-Scale, Real-World Migs Study
CI
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday
MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Extend Gains to Premarket
MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Jump After Hours
MT
Sight Sciences, Inc. Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT At the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
CI
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q4 Revenue $18.8M, vs. Street Est of $19.4M
MT
Sight Sciences, Inc. Provides Earnings Guidance for the Year 2024
CI
Sight Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sight Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Sight Sciences, Inc. Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting
CI
Sight Sciences Expects Lower Q4, Higher Full-Year 2023 Revenue
MT
Sight Sciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SGHT Stock
  4. News Sight Sciences, Inc.
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW